A detailed history of Lee Financial CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Lee Financial CO holds 1,688 shares of LLY stock, worth $1.38 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,688
Previous 1,547 9.11%
Holding current value
$1.38 Million
Previous $1.2 Million 27.02%
% of portfolio
0.25%
Previous 0.2%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $102,206 - $128,174
141 Added 9.11%
1,688 $1.53 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $60,996 - $81,604
103 Added 7.13%
1,547 $1.2 Million
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $27,835 - $32,813
53 Added 3.81%
1,444 $841,000
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $40,861 - $56,334
94 Added 7.25%
1,391 $747,000
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $107,326 - $143,507
306 Added 30.88%
1,297 $608,000
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $24,539 - $28,820
-79 Reduced 7.38%
991 $340,000
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $16,077 - $18,733
50 Added 4.9%
1,070 $391,000
Q3 2022

Nov 01, 2022

BUY
$296.48 - $337.87 $1,778 - $2,027
6 Added 0.59%
1,020 $329,000
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $13,379 - $15,708
48 Added 4.97%
1,014 $328,000
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $234 - $291
-1 Reduced 0.1%
966 $277,000
Q4 2021

Feb 08, 2022

BUY
$224.85 - $279.04 $3,372 - $4,185
15 Added 1.58%
967 $268,000
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $2,880 - $3,545
13 Added 1.38%
952 $219,000
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $27,283 - $32,836
200 Added 27.06%
939 $154,000
Q1 2020

May 07, 2020

SELL
$119.05 - $147.35 $77,382 - $95,777
-650 Reduced 46.8%
739 $103,000
Q1 2019

Apr 30, 2019

BUY
$111.31 - $131.02 $72,351 - $85,163
650 Added 87.96%
1,389 $180,000
Q3 2018

Nov 07, 2018

SELL
$85.86 - $107.31 $23,954 - $29,939
-279 Reduced 27.41%
739 $79,000
Q1 2018

May 09, 2018

SELL
$74.21 - $87.6 $14,322 - $16,906
-193 Reduced 15.94%
1,018 $79,000
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $19,173 - $20,566
234 Added 23.95%
1,211 $102,000
Q3 2017

Nov 07, 2017

BUY
$77.07 - $85.54 $75,297 - $83,572
977
977 $84,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lee Financial CO Portfolio

Follow Lee Financial CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial CO with notifications on news.